Scutellaria baicalensis: benefits, dosage, contraindications

Anti-inflammatory

Scutellaria shows significant anti-inflammatory activity, supported by in vitro and in vivo research. Its key components, baicalin and wogonin, influence various inflammatory mediators, including cytokines, nitric oxide, and eicosanoids. Studies in mice have confirmed its effectiveness in reducing several inflammatory markers, including those involved in allergic processes. Baicalin may act by inhibiting chemokines, while wogonin may reduce microglial cell motility, in part via inhibition of NF-κB.

Usages associés

Neurological

Many in vitro and in vivo studies have demonstrated the neuroprotective effects of flavonoids derived from Scutellaria. They suggest that Scutellaria flavones prevent neural damage through a strong antioxidant effect (reduction of lipid peroxidation markers), by moderating inflammation and increasing GABAergic signaling (anxiolytic and anticonvulsant effect), and that wogonin (a component of Scutellaria) exerts a neurogenic action, based on in vitro and in vivo evidence. An in vivo study in rats subjected to permanent global ischemia showed that daily oral doses of Scutellaria flavonoids (35 mg/kg) for 19 to 20 days significantly increased learning and memory abilities and attenuated neuronal damage. A follow-up in vivo study demonstrated that the flavonoid fraction also reduced neuronal damage and memory deficits after permanent cerebral ischemia. The Huang lian jie du tang is an important multi-herb Chinese remedy containing Scutellaria baicalensis, which is used clinically to treat cerebral ischemia. It also appears that Scutellaria may play a role in neurodegenerative disorders such as Parkinson's disease.

Usages associés

Anticancer

Scutellaria is traditionally used in alternative medicine for the treatment of cancer, notably prostate cancer. Scientific studies, both in animals and in vitro, have explored its anticancer properties. These investigations suggest that Scutellaria induces apoptosis (programmed cell death) by inhibiting certain cellular pathways and by reducing inflammatory cytokines and eicosanoids. Furthermore, in vitro studies indicate that Scutellaria may prevent the formation of new blood vessels that feed tumors, a process known as antiangiogenesis, possibly by influencing specific signaling pathways.

Usages associés

Antiallergic

Various flavonoids from Baikal Scutellaria, including wogonin and baicalein, have been shown to inhibit histamine release from rat mast cells. These flavonoids also attenuate allergic reactions, both immediate and delayed, by acting on IgE antibodies in mice and by reducing histamine release in human mast cells. Additionally, compounds such as luteolin and baicalin reduce histamine and other inflammatory mediators. Scutellaria has proven to be as effective, if not more so, than some conventional antiallergic drugs in suppressing allergic reactions.

Usages associés

Antiviral

Scutellaria has demonstrated significant antiviral effects. In particular, Scutellaria extract inhibits the replication of hepatitis C and influenza A viruses, including the H1N1 and H3N2 strains. This inhibition is mediated by baicalin, a flavonoid that targets neuraminidase, an enzyme crucial for viral replication. Baicalin inhibits other viruses: infection by HIV-1 at the level of viral entry and the early activation of an antigen of the Epstein-Barr virus. Furthermore, Scutellaria inhibits viral replication in part by preventing the fusion of viral envelopes with the endosome/lysosome membrane, which occurs at the beginning of the virus infection cycle.

Hepatoprotective

Baicine, baicalin, and wogonin, flavonoids from Scutellaria baicalensis, have shown hepatoprotective effects. These compounds reduce toxicity related to different chemicals, as indicated by decreases in liver enzymes (aspartate transaminase [AST] and alanine aminotransferase [ALT]) and histopathological analyses. Baicine, in particular, significantly increases levels of TNF-α and IL-6 (inflammatory markers), suggesting potential in liver regeneration after induced injury.

Usages associés

Anxiolytic

Research has shown that wogonine, baicaleine, scutellaréine and baicaline, all flavonoids, bind to the benzodiazepine site of the GABA-A receptor, with decreasing levels of efficacy, which plays a role in regulating neuronal excitability and anxiety. Orally administered wogonine interacts with these receptors and produces an anxiolytic effect similar to diazepam (an anti-anxiety medication), but without sedation or muscle relaxation. Other flavones such as oroxylin A and K36 also act on this site and have shown anxiolytic activity. Additionally, wogonine has GABA-mediated anticonvulsant effects.

Antibacterial

Adding baicéine to standard antibiotic therapy against multidrug-resistant Staphylococcus aureus increases the effectiveness of the antibiotic ciprofloxacin. This likely occurs because baicéine prevents the antibiotic from being expelled from the bacterium, a common mechanism of bacterial resistance. This finding offers hope in treating resistant bacterial strains. Furthermore, baicaline and Scutellaria baicalensis have been shown to be effective against Helicobacter pylori, with baicaline being more effective than the whole plant extract.

Lipid-lowering

Animal studies indicate that Scutellaria can reduce total cholesterol, triglyceride levels, and LDL-C (bad cholesterol), while increasing HDL-C (good cholesterol) levels. Additionally, wogonine, a component of Scutellaria, inhibits MCP-1 production by endothelial cells, suggesting potential benefit in treating inflammatory and vascular disorders, including atherosclerosis.

Antiandrogenic

Scutellaria is traditionally used for prostate cancer and as an anti-inflammatory agent. In an animal model of benign prostatic hyperplasia, Baikal skullcap inhibited inflammation and cell proliferation, probably by inhibiting the 5-alpha reductase.

Hypoglycemic

Scutellaria may be beneficial in diabetes management. Human studies have shown that it has a moderate effect on postprandial glucose levels, but not on fasting glucose levels. In animals, baicalin, one of its components, inhibits alpha-glucosidase, an enzyme involved in carbohydrate digestion. In addition, baicalin appears to reduce elevated insulin levels following a high-fat diet and to inhibit intestinal sucrase according to in vitro research.

Usages associés